Genus Lifesciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genus lifesciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genus Lifesciences Today - Breaking & Trending Today

Granules India receives USFDA approval for Potassium Chloride Oral Solution


Granules India announced today that the US Food & Drug Administration (US FDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI)., a wholly owned
foreign subsidiary of Granules India, for Potassium Chloride Oral Solution USP, 20 mEq/15 mL (10%)
and 40 mEq/15 mL (20%).
It is bioequivalent to the reference listed drug product (RLD), Potassium Chloride
Oral Solution, 20 mEq/15 mL (10%) and 40 mEq/15 mL (20%), of Genus Lifesciences, Inc.
The product would
be available in bottle of 473 ml and is expected to be launched shortly.
Potassium Chloride is indicated for the treatment and prophylaxis of hypokalemia with or without
metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose ....

Granules Pharmaceuticals Inc , Us Food Drug Administration , Genus Lifesciences Inc , Granules India , Drug Administration , Abbreviated New Drug Application , Granules Pharmaceuticals , Potassium Chloride Oral Solution , Genus Lifesciences , Chloride Oral , Capital Market , Physical Sciences , Chemical Elements , Dietary Minerals , Electrolyte Disturbances , Metal Halides , Metabolic Alkalosis , Potassium Chloride , துகள்கள் மருந்துகள் இன்க் , பேரினம் ஆயுள் அறிவியல் இன்க் , துகள்கள் இந்தியா , துகள்கள் மருந்துகள் , படாஸீயம் குளோரைடு வாய்வழி தீர்வு , பேரினம் ஆயுள் அறிவியல் , குளோரைடு வாய்வழி , மூலதனம் சந்தை ,